Market Size of Global Foot and Mouth Disease Vaccines Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 6.50 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Foot & Mouth Disease Vaccines Market Analysis
The Foot and mouth disease vaccines market is expected to register a CAGR of 9.8% over the forecast period.
COVID-19 had a significant impact on the growth of the market during the pandemic period. Supply disruption and shortages of veterinary medicines were observed in several countries, primarily due to the temporary lockdowns of manufacturing sites, export bans, and increased demand for COVID-19 medicines. Governments took measures to mitigate the supply of medicines. Certain specific and precautionary guidelines were given to veterinary professionals to treat companion animals during the COVID-19 pandemic by the Centers for Disease Control and Prevention in July 2020. Also, the incidence of foot and mouth disease in animals amidst COVID-19 is expected to contribute to the growth of the market. For instance, in April 2021, foot and mouth disease struck Arunachal Pradesh amid COVID-19 infections, affecting semi-wild mithuns across the Central and Eastern landscapes of the frontier North-Eastern State in India. Such circumstances led to the demand for the foot and mouth disease vaccine during the pandemic period. Thus, COVID-19 had a significant impact on the growth of the market.
The prevention and treatment of deadly animal diseases are key market indicators for the vaccine market. Certain factors such as increasing incidences of zoonotic diseases, increasing demand for animal products, and rising R&D activities in animal healthcare cause foot and mouth-related diseases are expected to contribute to the growth of the market during the forecast period. The article titled "Novel Foot and Mouth Disease Vaccine platform: Formulations for safe and DIVA compatible FMB vaccines with improved potency" published in September 2020 mentioned that the foot and mouth disease- LL3B3D vaccine platform, undergoing development in the United States, provides opportunities for safer vaccine production with full compatibility in support of the global foot and mouth disease virus control and eradication initiatives.
Zoonotic diseases are naturally transmitted from animals to humans. Adverse climatic transformations and rapid globalization are the major factors increasing the cases of zoonotic diseases over the past decades. Zoonotic diseases are quite common around the world. According to the scientists of the Centers for Disease Control and Prevention (CDC) in July 2021, over 6 out of every 10 known infectious diseases in humans are spread via animals, moreover, 3 out of every 4 new or emerging infectious diseases are spread from animals. So, it is evident that these diseases are major public health problems worldwide.
Thus, the above-mentioned factors are expected to drive the growth of the market during the forecast period. However, high storage costs for vaccines are expected to hamper the growth of the market over the forecast period.
Foot & Mouth Disease Vaccines Industry Segmentation
As per the scope of the report, Foot and Mouth Disease (FMD) is an infectious disease, which majorly affects cattle, sheep, goats, and swine. FMD occurs in the animal population and poses a serious threat around the world. Foot and Mouth Disease is caused by an Apthovirus of the family Picornaviridae. The Foot and Mouth Disease Vaccine market is segmented by Product Type (Conventional Vaccines and Emergency Vaccines), Animal Type(Cattle, Sheep and Goat, Pig and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Product | |
| Conventional Vaccines | |
| Emergency Vaccines |
| By Animal Type | |
| Cattle | |
| Sheep and goat | |
| Pig | |
| Others |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Foot and Mouth Disease Vaccines Market Size Summary
The foot and mouth disease vaccines market is poised for significant growth, driven by increasing incidences of zoonotic diseases and the rising demand for animal products. The market's expansion is further supported by advancements in research and development within animal healthcare, such as the development of the foot and mouth disease-LL3B3D vaccine platform in the United States. This platform aims to enhance vaccine safety and compatibility, aligning with global efforts to control and eradicate the disease. The market's growth trajectory is also influenced by the high population of cattle worldwide, particularly in countries like China and Mexico, where cattle farming is a major economic activity. The launch of vaccination programs and heightened awareness about cattle diseases and zoonosis are expected to bolster market demand in the coming years.
Regionally, North America stands out as a significant contributor to the foot and mouth disease vaccines market, benefiting from advanced animal healthcare programs and increased awareness of animal health. The region's market growth is propelled by the need for effective and rapid treatment options due to the rising disease burden in animals. The presence of global and regional players, such as Biogénesis Bagó, Boehringer Ingelheim GmbH, and Merck & Co. Inc., adds to the market's competitive landscape. Initiatives like the National Animal Disease Control Programme in India and livestock vaccination programs in Indonesia further underscore the global commitment to combating foot and mouth disease. Despite the market's moderate fragmentation, these factors collectively drive the market's growth prospects over the forecast period.
Global Foot and Mouth Disease Vaccines Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Incidences of Zoonotic Diseases
-
1.2.2 Increasing Demand for Animal Product
-
1.2.3 Rising R&D Activities in Animal Healthcare
-
-
1.3 Market Restraints
-
1.3.1 High Storage Costs for Vaccines
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Product
-
2.1.1 Conventional Vaccines
-
2.1.2 Emergency Vaccines
-
-
2.2 By Animal Type
-
2.2.1 Cattle
-
2.2.2 Sheep and goat
-
2.2.3 Pig
-
2.2.4 Others
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Global Foot and Mouth Disease Vaccines Market Size FAQs
What is the current Global Foot and Mouth Disease Vaccines Market size?
The Global Foot and Mouth Disease Vaccines Market is projected to register a CAGR of 6.5% during the forecast period (2024-2029)
Who are the key players in Global Foot and Mouth Disease Vaccines Market?
Biogénesis Bagó, Boehringer Ingelheim GmbH, Merck , VECOL S.A and VETAL Animal Health Products are the major companies operating in the Global Foot and Mouth Disease Vaccines Market.
